Therapeutics company focused on developing novel therapies for periodontal disease. Founding team led by experts in disease biology and key opinion leaders in the industry. Spun out of Yale University in 2021 (Active)

Clinical-stage chronic wound care diagnostic company focused on predictive analytics. Spun out of Drexel University in 2010 (Exited 2017)

Clinically-supported digestive solutions leveraging the work of Dr John Geibel. Profitable within the first 3 months of launch. Spun out of Yale University in 2017. (Exited 2019)

Leaders in geometric, graph-based and manifold learning. Spun out of Yale University in 2024. (Active)

Clinical-stage therapeutics company focused on pediatric epilepsy. Spun out of Harvard Medical School in 2011. (Merged with Biscayne Pharmaceuticals 2015; Sold to Supernus Pharmaceuticals in 2018)

Development-stage therapeutics company leveraging platform chemistries for mitochondrial drug delivery. First to publish data on multiple checkpoint inhibition with a small molecule (Kolb et al. ACS Nano. 2020 Sep 22;14(9):11055-11066.) Spun out of University of Georgia in 2014 (Patents Sold; Exited 2018)